Glenda Halliday
Glenda Halliday
Glenda Halliday
The University of Sydney
Professor Halliday is a research neuropathologist specialising in neurodegeneration, including Parkinson's disease, non-Alzheimer dementias, and degenerative motor syndromes.
Danny Hatters
Glenda Halliday
Glenda Halliday
The University of Melbourne
Danny runs a research group focused on the molecular consequences of protein aggregation in neurodegenerative diseases with a focus on amyotrophic lateral sclerosis and Huntington’s Disease
Scott Ayton
Florey Institute of Neuroscience and Mental Health
Scott pursues both laboratory (metabolism & physiology) and clinical research (fluid & imaging biomarkers, clinical trial) in dementia to discover the underlying causes, to develop and implement diagnostics, and to intervene with new therapeutics.
Rebecca Nisbet
Florey Institute of Neuroscience and Mental Health
Dr Nisbet is the head of the Antibody Therapeutics Group. Her team focuses on the development of next generation active and passive immunotherapies for the treatment and prevention of Alzheimer’s disease and related dementias.
Nic Dzamko
Nic Dzamko
The University of Sydney
The Dzamko lab is focussed on understanding the causes of, and developing treatments for, Parkinson's disease, with particular interests in autophagy/lysosomal function and innate immunity.
Eleanor Drummond
Eleanor Drummond
Eleanor Drummond
The University of Sydney
The Drummond lab studies the brain protein changes and disease mechanisms linked to Alzheimer’s disease and primary tauopathies.
Helen Murray
Eleanor Drummond
Eleanor Drummond
University of Auckland
Helen leads the Brain Injury and Neurodegeneration lab at the Centre for Brain Research. Her group studies the neuropathology of these conditions using postmortem human brain tissue and highly multiplexed immunohistochemistry.
Jürgen Götz
Eleanor Drummond
Jürgen Götz
The University of Queensland
Jürgen leads a team that explores tau-related pathomechanisms in Alzheimer’s disease. It further develops novel anti-tau antibodies and investigates low-intensity ultrasound as a novel therapy in animal models and clinical trials.
Leon Smyth
Michael Lazarou
Michael Lazarou
Washington University in St. Louis
Dr Smyth is a neuroimmunologist focused on the meninges that surround the brain. In particular, he is interested in how the stromal cells of the meninges orchestrate neuroimmune communication and how this affects brain health.
Michael Lazarou
Michael Lazarou
Michael Lazarou
Walter and Eliza Hall Institute
Michael’s team studies the neuronal cell biology of mitophagy, an important quality control pathway that maintains mitochondrial and neuronal health.
Victor Anggono
The University of Queensland
The Anggono Lab focuses on the molecular and cellular mechanisms underlying neuronal communications and plasticity, and how they are perturbed in neurological disorders.
Clare Parish
Florey Institute of Neuroscience and Mental Health
Melanie Bahlo
Melanie Bahlo
Walter and Eliza Hall Institute
Professor Bahlo is the head of the Statistical Genetics laboratory at WEHI. Her group’s focus is on identifying and understanding the genetic factors that influence neurological and retinal disorders.
Sophia Davidson
Speaker to be announced
Speaker to be announced
Hudson Institute of Medical Research
The Davidson lab studies monogenic diseases to explore the relationship between cell stress and inflammation and their impact on neuronal development and function.
Speaker to be announced
Speaker to be announced
Speaker to be announced
Details to come